全文获取类型
收费全文 | 208666篇 |
免费 | 36178篇 |
国内免费 | 2569篇 |
专业分类
耳鼻咽喉 | 5786篇 |
儿科学 | 6666篇 |
妇产科学 | 3184篇 |
基础医学 | 10977篇 |
口腔科学 | 2408篇 |
临床医学 | 32785篇 |
内科学 | 59703篇 |
皮肤病学 | 8130篇 |
神经病学 | 20581篇 |
特种医学 | 8368篇 |
外国民族医学 | 5篇 |
外科学 | 51431篇 |
综合类 | 846篇 |
现状与发展 | 72篇 |
一般理论 | 47篇 |
预防医学 | 11112篇 |
眼科学 | 4502篇 |
药学 | 5233篇 |
中国医学 | 77篇 |
肿瘤学 | 15500篇 |
出版年
2024年 | 545篇 |
2023年 | 5088篇 |
2022年 | 1842篇 |
2021年 | 4952篇 |
2020年 | 7021篇 |
2019年 | 3852篇 |
2018年 | 9332篇 |
2017年 | 8632篇 |
2016年 | 9774篇 |
2015年 | 10028篇 |
2014年 | 17820篇 |
2013年 | 18567篇 |
2012年 | 10447篇 |
2011年 | 10653篇 |
2010年 | 13004篇 |
2009年 | 16569篇 |
2008年 | 9922篇 |
2007年 | 8298篇 |
2006年 | 10528篇 |
2005年 | 7635篇 |
2004年 | 6495篇 |
2003年 | 5322篇 |
2002年 | 5046篇 |
2001年 | 4138篇 |
2000年 | 3263篇 |
1999年 | 3537篇 |
1998年 | 4207篇 |
1997年 | 3882篇 |
1996年 | 3685篇 |
1995年 | 3491篇 |
1994年 | 2202篇 |
1993年 | 1818篇 |
1992年 | 1556篇 |
1991年 | 1548篇 |
1990年 | 1174篇 |
1989年 | 1271篇 |
1988年 | 1120篇 |
1987年 | 938篇 |
1986年 | 966篇 |
1985年 | 789篇 |
1984年 | 661篇 |
1983年 | 613篇 |
1982年 | 618篇 |
1981年 | 497篇 |
1980年 | 469篇 |
1979年 | 352篇 |
1978年 | 375篇 |
1977年 | 440篇 |
1975年 | 302篇 |
1972年 | 314篇 |
排序方式: 共有10000条查询结果,搜索用时 458 毫秒
111.
112.
113.
114.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
115.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
116.
A hypothesis for reactivation of pulmonary tuberculosis: How thoracic wall shape affects the epidemiology of tuberculosis
下载免费PDF全文
![点击此处可从《Clinical anatomy (New York, N.Y.)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Aaron R. Casha Liberato Camilleri Alexander Manché Ruben Gatt Daphne Attard Wiktor Wolak Krzysztof Dudek Marilyn Gauci Christopher Giordimaina Joseph N. Grima 《Clinical anatomy (New York, N.Y.)》2015,28(5):614-620
This study was aimed at determining the cause for the high incidence of tuberculosis (TB) reactivation occurring in males with a low body mass index (BMI). Current thinking about pulmonary TB describes infection in the lung apex resulting in cavitation after reactivation. A different hypothesis is put forward for TB infection, suggesting that this occurs in subclinical apical cavities caused by increased pleural stress due to a low BMI body habitus. A finite element analysis (FEA) model of a lung was constructed including indentations for the first rib guided by paramedian sagittal CT reconstructions, and simulations were conducted with varying antero‐posterior (AP) diameters to mimic chests with a different thoracic index (ratio of AP to the transverse chest diameters). A Pubmed search was conducted about gender and thoracic index, and the effects of BMI on TB. FEA modeling revealed a tenfold increase in stress levels at the lung apex in low BMI chests, and a four‐fold increase with a low thoracic index, r2 = 0.9748 P < 0.001. Low thoracic index was related to BMI, P = 0.001. The mean thoracic index was statistically significantly lower in males, P = 0.001, and increased with age in both genders. This article is the first to suggest a possible mechanism linking pulmonary TB reactivation to low BMI due to the flattened thoracic wall shape of young male adults. The low thoracic index in young males may promote TB reactivation due to tissue destruction in the lung apex from high pleural stress levels. Clin. Anat. 28:614–620, 2015. © 2015 Wiley Periodicals, Inc. 相似文献
117.
118.
119.
Christopher J. Destache David J. Guervil Keith S. Kaye 《International journal of antimicrobial agents》2019,53(5):644-649
Background
The clinical experience of ceftaroline fosamil (CPT-F) therapy for Gram-positive infective endocarditis is reported from CAPTURE, a retrospective study conducted in the USA.Methods
Data, including patient demographics, medical history, risk factors, microbiological aetiology and clinical outcomes, were collected by review of patient charts between September 2013 and February 2015.Results
Patients (n=55) with Gram-positive endocarditis were treated with CPT-F. The most common risk factors were intravascular devices (43.6%), diabetes mellitus (40.0%) and injection drug use (38.2%). The most commonly isolated pathogens were meticillin-resistant Staphylococcus aureus (MRSA; 80%), meticillin-susceptible S. aureus (MSSA; 7.3%) and coagulase-negative staphylococci (7.3%). CPT-F was given as first-line therapy in 7.3% of patients and as second-line or later therapy in 92.7% of patients, and as monotherapy in 41.8% of patients and as concurrent therapy in 58.2% of patients. Clinical success was observed in 82.6% (19/23) of patients treated with CPT-F as monotherapy. In patients treated with CPT-F as first-line therapy or second-line or later therapy, 75.0% (3/4) and 70.6% (36/51) achieved success, respectively. Clinical success was observed in 77.3% (34/44) of patients with MRSA and 25% (1/4) of patients with MSSA. Two patients discontinued treatment with CPT-F due to an adverse event.Conclusions
CPT-F treatment was associated with a high rate of clinical success in patients with Gram-positive infective endocarditis, including those with risk factors and infections caused by MRSA. A high rate of clinical success was observed in patients treated with CPT-F used as first- line therapy or second-line or later therapy, or as monotherapy or in combination with other antibiotics. 相似文献120.
Christopher N. Cooley Tyler J. Beranek Matthew A. Warpinski Robert Alexander Amanda O. Esquivel 《The American journal of emergency medicine》2019,37(2):199-203